1. Home
  2. RGCO vs VYGR Comparison

RGCO vs VYGR Comparison

Compare RGCO & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RGC Resources Inc.

RGCO

RGC Resources Inc.

N/A

Current Price

$21.84

Market Cap

229.4M

Sector

Utilities

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.46

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGCO
VYGR
Founded
1912
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.4M
203.6M
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
RGCO
VYGR
Price
$21.84
$3.46
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$22.70
$16.50
AVG Volume (30 Days)
13.3K
439.1K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
3.93%
N/A
EPS Growth
11.21
N/A
EPS
1.37
N/A
Revenue
$95,334,212.00
$10,135,000.00
Revenue This Year
$11.06
$34.04
Revenue Next Year
$2.89
$7.92
P/E Ratio
$16.05
N/A
Revenue Growth
12.63
N/A
52 Week Low
$20.55
$2.94
52 Week High
$27.17
$5.55

Technical Indicators

Market Signals
Indicator
RGCO
VYGR
Relative Strength Index (RSI) 45.76 60.37
Support Level $20.81 $3.29
Resistance Level $22.80 $4.31
Average True Range (ATR) 0.51 0.14
MACD 0.11 0.04
Stochastic Oscillator 57.99 80.00

Price Performance

Historical Comparison
RGCO
VYGR

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: